0001104659-20-078323.txt : 20200630
0001104659-20-078323.hdr.sgml : 20200630
20200629215243
ACCESSION NUMBER: 0001104659-20-078323
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200625
FILED AS OF DATE: 20200629
DATE AS OF CHANGE: 20200629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Iwicki Mark T
CENTRAL INDEX KEY: 0001415537
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38150
FILM NUMBER: 201000190
MAIL ADDRESS:
STREET 1: 84 WATERFORD DRIVE
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001479419
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270604595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 120
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 781-996-5252
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 120
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
a4.xml
4
X0306
4
2020-06-25
0
0001479419
Kala Pharmaceuticals, Inc.
KALA
0001415537
Iwicki Mark T
C/O KALA PHARMACEUTICALS, INC.
490 ARSENAL WAY, SUITE 120
WATERTOWN
MA
02472
1
1
0
0
Chief Executive Officer
Common Stock
2020-06-25
4
A
0
49560
0
A
49560
D
Grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued employment with the Issuer, the RSUs will vest as to 50% of the shares underlying the RSUs on June 25, 2021 and the remaining 50% of the shares underlying the RSUs on June 25, 2022.
Includes 49,560 unvested RSUs.
/s/ Eric Trachtenberg, Attorney-in-Fact
2020-06-29